1Chen F, Castranova V, Shi X. New Insights into the Role of Nuclear Factor-B in Cell Growth Regulation [ J ]. Am J Pathol, 2001,159 (2) :387-397.
2de Martin R, Hoeth M, Hofer-Warbinek R, et el. The transcription factor NF-kB and the regulation of vascular cell function[ J ]. Arterioscler Thromb Vase Biol,2000,20( 11 ) : e83-88.
3Bierhaus A, Schiekofer S, Schwaninger M, et al. Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-B [ J ].Diabetes, 2001,50(12) : 2792-2808.
4Marumo T, Schini-Kerth VB, Busse R. Vascular Endothdual Growth Factor Activates Nuclear Factor-B and Induces Monocyte Chemoattracrant Protein-1 in Bovine Retinal Endothelial Cells[J]. Diabetes, 1999,48(5) : 1131-1137.
5Li W,Yanoff M, Liu X, et al. Retinal capallary pericyte apoptosis in early human diabetic retinopathy [ J ]. Chin Med J (Engl), 1997, 110(9) :659-663.
6Remeo G, Liu WH, Asnaghi V, et el. Activated of nuclear factor-B induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes[ J] .Diabetes,2002,51(7) :2241-2248.
7Jossen AM, Poulaki V, Mitsiades N, et al. Nonstereidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression[ J]. FASEB J,2002,16(3) :438-440.
8Hammes HP,Du X,Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy[ J]. Nat Med,2003,9(3) :294-299.
9Yoshida S, Ono M, Shono T, et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor alphadependent angiogenesis[ J]. Mol Cell Biol, 1997,17(7) :4015-4023.
10Yoshida A, Yshida S, Ishibashi T, et al. Suppression of retinal neovascularization by the NF-kB inhibitor Pyrrolidine dithocarbamate in mice[J]. Invest Ophthalmol Vis Sci, 1999,40(7) : 1624-1629.
